Comera Life Sciences Holdings, Inc.·4

Nov 13, 6:31 AM ET

Clarke Dorothy J 4

4 · Comera Life Sciences Holdings, Inc. · Filed Nov 13, 2023

Insider Transaction Report

Form 4
Period: 2023-11-07
Transactions
  • Award

    Stock Option (Right to Purchase

    2023-11-07+14,20014,200 total
    Exercise: $0.35Exp: 2033-11-07Common Stock (14,200 underlying)
Footnotes (1)
  • [F1]Granted pursuant to the Comera Life Sciences Holdings, Inc. 2022 Equity and Incentive Plan. The stock option shall vest over three (3) years, with one-third of the shares of common stock underlying the option vesting on November 7, 2024, and the remainder vesting in equal monthly installments thereafter.

Documents

1 file
  • 4
    form4.xmlPrimary

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES